The election of Donald Trump is clearly a "mixed bag" for technology investors and investment bankers, says Ted Smith, president of Union Square Advisors. Trump has also talked about being a trustbuster with regard to some of the bigger deals in the markets and there has been a resurgence of activity by traditional large corporate acquirers this year including AT&T (T) , Microsoft (MSFT) , Oracle (ORCL) and Cisco (CSCO) . There has also been widespread divestiture activity by the likes of Hewlett Packard Enterprise (HPE) , Intel (INTC) and Dell as these companies seek to reposition themselves for improved revenue growth. Smith expects the already high level of tech-focused activity by private equity firms to continue in 2017. There have been 10 take-private transactions valued at over $1 billion already announced in 2016, more than any other year in the past decade. As for the IPO market, Smith expects it to pick up in 2017 after a moribund 2016.
More from Video
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Breaking down an approach to the long side of this biotech stock.